Digital Spatial Profiling
Rapid IO Signature Development
IO 360™ GX Panel
Faster than qPCR. Simpler than NGS.
Expertly Curated. Ready to Use.
Cell Press Supplement
Pathological Mechanisms of Neurodegeneration
Small Sample. Big Insight.
nCounter® Analysis System
More insights from
Prosigna® Breast Cancer Prognostic Gene Signature Assay
Empowering personalized treatment decisions
Learn More *See product pages for regulatory status information
on actionable answers
nFORM BLOG- Neuroscience
Dr. Oleg Butovsky discusses his lab’s focus on the fundamental questions surrounding microglia biology and why these cells are so important for the potential treatment of a wide range of neurological diseases.
April 19, 2018
nFORM BLOG- Digital Spatial Profiling
Michael Davies, MD, PhD, from the MD Anderson Cancer Center, shares some of his early research data in utilizing Digital Spatial Profiling. Dr. Davies and his team investigated protein signaling pathways and anti-tumor immune response in heterogeneous melanoma as well as RNA expression studies.
May 10, 2018
nCounter® Analysis in Complex Biology:
Gene expression profile predicts response to pembrolizumab
A video review of JCI publication by Ayers, et al:
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Morphology-Driven, High-Plex Spatial Analysis of Immune Protein Expression in Lung Cancer - June 7, 2018 - 9:30am PST
David Rimm, MD, PhD, Yale University and Doug Hinerfeld, PhD, NanoString
Digital Spatial Profiling (DSP) Technology has the potential to overcome traditional IHC and QIF challenges with oligo-barcoded antibodies and digital readouts for high multi-plexing capability of 800+ targets. This webinar presents data from testing DSP against QIF to evaluate technical performance and how DSP was utilized to identify potential prognostic signatures in lung cancers treated with an immune checkpoint inhibitor.
The microRNA regulatory landscape of MSC-derived exosomes: a systems view - aired May 9 2018 - 10:30 a.m. (PST)
Juliane Nguyen, PharmD, PhD, Assistant Professor, Department of Pharmaceutical Sciences, School of Pharmacy, University at Buffalo
The data presented in the webinar has helped define the miRNA landscape of MSC exosomes, establish their biological functions through network analyses at a system level, and provide a platform for modulating the overall phenotypic effects of exosomes using nCounter miRNA assays from NanoString Technologies.
Cost Effective, Robust Digital Gene Expression Profiling of Up to 96 Targets in 96 Samples for Cell Line Screening with nCounter® PlexSet™ Reagents - aired May 10 2018 - 10:30 a.m. (PST)
Chris Merritt, PhD, NanoString
Cell line screening studies require highly efficient protocols for studying many samples in parallel. We have developed a lyse-and-go protocol for digital gene expression profiling of up to 96-samples by 96-genes in parallel. This protocol is based on nCounter PlexSet Reagents which enable multiplexing of samples and gene targets.